Interstitial lung disease associated with systemic lupus erythematosus : a monocentric study of 23 cases.

l. deneuville (paris, France), K. Sacre (paris, France), M. Debray (paris, France), P. Nicaise-Roland (paris, France), B. Crestani (paris, France), R. Borie (paris, France)

Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
l. deneuville (paris, France), K. Sacre (paris, France), M. Debray (paris, France), P. Nicaise-Roland (paris, France), B. Crestani (paris, France), R. Borie (paris, France). Interstitial lung disease associated with systemic lupus erythematosus : a monocentric study of 23 cases.. 2344

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung involvement in systemic lupus erythematosus (SLE) - our own experience
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Lung abnormalities in patients with systemic lupus erythematosus
Source: Eur Respir J 2001; 18: Suppl. 33, 225s
Year: 2001

Examining pulmonary function measures in patients with systemic lupus erythematosus (SLE)
Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases
Year: 2020

Shrinking lung syndrome (SLS) associated with systemic lupus erythematosus (SLE): A series of cases in a university hospital.
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019



Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus
Source: Eur Respir Rev 2011; 20: 277-286
Year: 2011



Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease
Source: Eur Respir Monogr 2019; 86: 106-123
Year: 2019


On diagnostics of pneumonitis in patients with lupus erythematosus (LE)
Source: Eur Respir J 2005; 26: Suppl. 49, 31s
Year: 2005

Systemic lupus erythematosus (SLE): Cyto- and chemokines as possible serum markers for pulmonary involvement?
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Management of PAH associated with systemic lupus erythematosus (SLE) or mixed connective tissue disease (MCTD): immunosuppressive therapy (IT) alone or combined with PAH specific therapies?
Source: Eur Respir J 2007; 30: Suppl. 51, 344s
Year: 2007

A functionally improved case of obstructive impairment caused by systemic lupus erythematosus
Source: Breathe, 17 (2) 200288; 10.1183/20734735.0288-2020
Year: 2021



The prevalence of respiratory disease in a cohort of patients with systemic lupus erythematosus (SLE) in a large Irish teaching hospital
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


The profile of lung scintigraphy in systemic lupus erythematosus with chronic pulmonary embolism:a cross-section
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020


Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011


Pulmonary hypertension in systemic lupus erythematosus – a retrospective analysis
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009


Cardio-pulmonary exercise testing in systemic lupus erythematosus patients
Source: Eur Respir J 2005; 26: Suppl. 49, 350s
Year: 2005

Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study
Source: ERJ Open Res, 4 (1) 00135-2017; 10.1183/23120541.00135-2017
Year: 2018



Effectiveness of ²Korargin² in the therapy of pulmonary arterial hypertension in patients with systemic lupus erythematosus
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
Source: Eur Respir J, 53 (2) 1800081; 10.1183/13993003.00081-2018
Year: 2019



Pulmonary arterial hypertension and systemic lupus erythematosus
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009